Ke Min-Hui, Huang Shu-Yan, Lin Wei-Gan, Xu Zhen-Guo, Zheng Xia-Xia, Liu Xian-Bao, Cheng You-Min, Li Zuan-Fang
Department of Proctology, The Second People's Hospital Affiliated with Fujian University of Traditional Chinese Medicine, Fuzhou 350003, Fujian Province, China.
Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian Province, China.
World J Gastrointest Surg. 2025 Apr 27;17(4):103494. doi: 10.4240/wjgs.v17.i4.103494.
Hemorrhoids, a prevalent chronic condition globally, significantly impact patients' quality of life. While various surgical interventions, such as external stripping and internal ligation, procedure for prolapse and hemorrhoids, and tissue selecting technique, are employed for treatment, they are often associated with postoperative complications, including unsatisfactory defecation, bleeding, and anal stenosis. In contrast, Xiaozhiling injection, a traditional Chinese medicine-based therapy, has emerged as a minimally invasive and effective alternative for internal hemorrhoids. This treatment offers distinct advantages, such as reduced dietary restrictions, broad applicability, and minimal induction of systemic inflammatory responses. Additionally, Xiaozhiling injection effectively eliminates hemorrhoid nuclei, prevents local tissue necrosis, preserves anal cushion integrity, and mitigates postoperative complications, including bleeding and prolapse. Despite its clinical efficacy, the molecular mechanisms underlying its therapeutic effects remain poorly understood, warranting further investigation.
To investigate the molecular mechanism underlying the therapeutic effect of Xiaozhiling injection in the treatment of internal hemorrhoids.
An internal hemorrhoid model was established in rats, and the rats were randomly divided into a modeling group [control group (CK group)] and a treatment group. One week after injection, Stereo-seq and electron microscopy were used to study the changes in gene expression and subcellular structures in fibroblasts.
Single-cell sequencing revealed differences in the expression and transcript levels of the genes collagen 3 alpha 1, decorin, and actin alpha 2 in fibroblasts between the CK group and the treatment group. Spatial transcriptome analysis revealed that genes of the sphingosine kinase 1 (Sphk1)/sphingosine-1-phosphate (S1P) pathway spatially overlapped with key genes of the transforming growth factor beta 1 pathway, namely, , S1P receptor, and transforming growth factor beta 1, in the treatment group. The proportion of fibroblasts was lower in the treatment group than in the CK group, and Xiaozhiling treatment had a significant effect on the proportion of fibroblasts in hemorrhoidal tissue. Immunohistochemistry revealed a significant increase in the expression of a fibroblast marker. Electron microscopy showed that the endoplasmic reticulum of fibroblasts contained a large amount of glycogen, indicating cell activation. Fibroblast activation and the expression of key genes of the Sphk1-S1P pathway could be observed at the injection site, suggesting that after Xiaozhiling intervention, the Sphk1-S1P pathway could be activated to promote fibrosis.
Xiaozhiling injection exerts its therapeutic effects on internal hemorrhoids by promoting collagen synthesis and secretion in fibroblasts. After Xiaozhiling intervention, the Sphk1-S1P pathway can be activated to promote fibrosis.
痔疮是一种全球普遍存在的慢性疾病,严重影响患者的生活质量。虽然采用了各种手术干预措施,如外痔剥离内痔结扎术、吻合器痔上黏膜环切术和组织选择性技术等进行治疗,但这些方法往往与术后并发症相关,包括排便不尽、出血和肛门狭窄。相比之下,消痔灵注射作为一种基于中药的疗法,已成为内痔微创且有效的替代治疗方法。这种治疗方法具有明显优势,如饮食限制减少、适用性广泛以及全身炎症反应诱导最小。此外,消痔灵注射能有效消除痔核,防止局部组织坏死,保持肛垫完整性,并减轻包括出血和脱垂在内的术后并发症。尽管其临床疗效显著,但其治疗效果的分子机制仍知之甚少,值得进一步研究。
探讨消痔灵注射治疗内痔的分子机制。
在大鼠中建立内痔模型,并将大鼠随机分为造模组[对照组(CK组)]和治疗组。注射1周后,采用空间转录组测序(Stereo-seq)和电子显微镜研究成纤维细胞中基因表达和亚细胞结构的变化。
单细胞测序显示,CK组和成纤维细胞中,胶原蛋白3α1、核心蛋白聚糖和肌动蛋白α2基因的表达和转录水平存在差异。空间转录组分析显示,治疗组中鞘氨醇激酶1(Sphk1)/鞘氨醇-1-磷酸(S1P)途径的基因与转化生长因子β1途径的关键基因,即S1P受体和转化生长因子β1,在空间上重叠。治疗组中成纤维细胞的比例低于CK组,消痔灵治疗对痔组织中成纤维细胞的比例有显著影响。免疫组织化学显示成纤维细胞标志物的表达显著增加。电子显微镜显示成纤维细胞的内质网含有大量糖原,表明细胞被激活。在注射部位可观察到成纤维细胞激活以及Sphk1-S1P途径关键基因的表达,这表明消痔灵干预后,Sphk1-S1P途径可被激活以促进纤维化。
消痔灵注射通过促进成纤维细胞中胶原蛋白的合成和分泌对内痔发挥治疗作用。消痔灵干预后,Sphk1-S1P途径可被激活以促进纤维化。